BMC Genomics (Jan 2020)
Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants
- Raphaël Leman,
- Hélène Tubeuf,
- Sabine Raad,
- Isabelle Tournier,
- Céline Derambure,
- Raphaël Lanos,
- Pascaline Gaildrat,
- Gaia Castelain,
- Julie Hauchard,
- Audrey Killian,
- Stéphanie Baert-Desurmont,
- Angelina Legros,
- Nicolas Goardon,
- Céline Quesnelle,
- Agathe Ricou,
- Laurent Castera,
- Dominique Vaur,
- Gérald Le Gac,
- Chandran Ka,
- Yann Fichou,
- Françoise Bonnet-Dorion,
- Nicolas Sevenet,
- Marine Guillaud-Bataille,
- Nadia Boutry-Kryza,
- Inès Schultz,
- Virginie Caux-Moncoutier,
- Maria Rossing,
- Logan C. Walker,
- Amanda B. Spurdle,
- Claude Houdayer,
- Alexandra Martins,
- Sophie Krieger
Affiliations
- Raphaël Leman
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Hélène Tubeuf
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Sabine Raad
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Isabelle Tournier
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Céline Derambure
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Raphaël Lanos
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Pascaline Gaildrat
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Gaia Castelain
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Julie Hauchard
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Audrey Killian
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Stéphanie Baert-Desurmont
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Angelina Legros
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Nicolas Goardon
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Céline Quesnelle
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Agathe Ricou
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Laurent Castera
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Dominique Vaur
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- Gérald Le Gac
- Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale
- Chandran Ka
- Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale
- Yann Fichou
- Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale
- Françoise Bonnet-Dorion
- Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié
- Nicolas Sevenet
- Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié
- Marine Guillaud-Bataille
- Service de Génétique, Institut Gustave Roussy
- Nadia Boutry-Kryza
- Lyon Neuroscience Research Center–CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon
- Inès Schultz
- Laboratoire d’Oncogénétique, Centre Paul Strauss
- Virginie Caux-Moncoutier
- Service de Génétique, Institut Curie
- Maria Rossing
- Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen
- Logan C. Walker
- Department of Pathology and Biomedical Science, University of Otago
- Amanda B. Spurdle
- Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute
- Claude Houdayer
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Alexandra Martins
- Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University
- Sophie Krieger
- Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse
- DOI
- https://doi.org/10.1186/s12864-020-6484-5
- Journal volume & issue
-
Vol. 21,
no. 1
pp. 1 – 12
Abstract
Abstract Background Branch points (BPs) map within short motifs upstream of acceptor splice sites (3’ss) and are essential for splicing of pre-mature mRNA. Several BP-dedicated bioinformatics tools, including HSF, SVM-BPfinder, BPP, Branchpointer, LaBranchoR and RNABPS were developed during the last decade. Here, we evaluated their capability to detect the position of BPs, and also to predict the impact on splicing of variants occurring upstream of 3’ss. Results We used a large set of constitutive and alternative human 3’ss collected from Ensembl (n = 264,787 3’ss) and from in-house RNAseq experiments (n = 51,986 3’ss). We also gathered an unprecedented collection of functional splicing data for 120 variants (62 unpublished) occurring in BP areas of disease-causing genes. Branchpointer showed the best performance to detect the relevant BPs upstream of constitutive and alternative 3’ss (99.48 and 65.84% accuracies, respectively). For variants occurring in a BP area, BPP emerged as having the best performance to predict effects on mRNA splicing, with an accuracy of 89.17%. Conclusions Our investigations revealed that Branchpointer was optimal to detect BPs upstream of 3’ss, and that BPP was most relevant to predict splicing alteration due to variants in the BP area.
Keywords